logo
Share SHARE
FONT-SIZE Plus   Neg

Intrexon Files For IPO Of Up To $125 Mln

Biotechnology company Intrexon Corp. has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission to raise up to $125 million in an initial public offering of common stock. The company did not specify the number of shares to be sold and the price range for the proposed offering.

The Germantown, Maryland based company plans to list on the New York Stock Exchange under the ticker symbol XON.

The company said in a preliminary prospectus that it plans to use the proceeds to fund continued investment in research and development platforms and its business development efforts.

Intrexon is a leader in the field of synthetic biology, an emerging and rapidly evolving discipline that applies engineering principles to biological systems

Intrexon, which was founded in 1998, is now controlled by Randal Kirk, who has been the chief executive of the company since 2005.

J.P. Morgan and Barclays are the joint bookrunners on the deal.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Ford Motor Co.(F) reported a profit for the second-quarter that declined 8.8 percent from last year, while total revenue increased about 6 percent. The company now sees risks challenging achieving 2016 guidance. ConocoPhillips on Thursday reported a loss for the second quarter that widened from last year, reflecting lower revenues and one-time charges. The results for the quarter missed analysts' estimates. However, the company raised its production outlook for the full-year. Like other companies in the oil industry, ConocoPhillips is struggling with lower oil prices. Bristol-Myers Squibb Co. on Thursday raised its earnings forecast for fiscal 2016 after reporting a significant profit in its second quarter, compared to prior year's loss. The results reflected the absence of prior year's hectic charge as well as strong revenue growth. Earnings per share and top line beat market estimates.
comments powered by Disqus
Follow RTT